Lule, S. Et Al. 2017. Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.. Journal of autoimmunity , vol.84 , 87-96.

Lule, S., Colpak, A. I., Balci-Peynircioglu, B., Gursoy-Ozdemir, Y., Peker, S., Kalyoncu, U., ... Can, A.(2017). Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.. Journal of autoimmunity , vol.84, 87-96.

Lule, S. Et Al. "Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.," Journal of autoimmunity , vol.84, 87-96, 2017

Lule, S. Et Al. "Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.." Journal of autoimmunity , vol.84, pp.87-96, 2017

Lule, S. Et Al. (2017) . "Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.." Journal of autoimmunity , vol.84, pp.87-96.

@article{article, author={S. Lule Et Al. }, title={Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.}, journal={Journal of autoimmunity}, year=2017, pages={87-96} }